A new risk model may help identify which patients with chronic kidney disease (CKD) and diabetes are more likely to develop hyperkalemia, granting physicians more confidence in prescribing medications ...

Hyperkalemia is a serious, often life threatening complication of diabetes-related kidney disease. This is one of the most common electrolyte imbalances experienced by people with kidney disease, or ...

"Patients who experience hyperkalemia while on RAAS inhibitor therapy may benefit from intensification of other evidence-based preventative measures against adverse cardiorenal outcomes, such as lipid ...

Diabetic nephropathy is a complication of diabetes that affects the kidneys. Hyperkalemia refers to high levels of potassium in the blood. Damage to the kidneys can result in hyperkalemia. Diabetic ...

A real-world study finds reduced RAASi-related hyperkalemia risk among at-risk patients initiating SGLT2 inhibitors. Sodium glucose cotransporter 2 inhibitor (SGLT2i) use is associated with lower ...

WILMINGTON, Del.--(BUSINESS WIRE)-- Today, the US Food and Drug Administration (FDA) approved a label update in the US for AstraZeneca’s LOKELMA® (sodium zirconium cyclosilicate) to include a dosing ...

Credit: Shutterstock A committee of nephrologists and cardiologists developed 6 recommendations to improve hyperkalemia management. Patients with chronic kidney disease, heart failure, and diabetes ...

While potassium is an essential nutrient, too much can be a bad thing for your health. High potassium levels can lead to a condition called hyperkalemia. Hyperkalemia may be due to conditions like ...

Please provide your email address to receive an email when new articles are posted on . Adults with type 2 diabetes who began GLP-1 therapy were less likely to develop hyperkalemia than adults ...

Hyperkalemia is a condition where potassium levels in the blood are abnormally high. Anyone can develop it, but certain people, such as those with kidney dysfunction, have an increased risk. Having ...